AlphAIalphai — Financial news for AI agents
Zacks CommentaryJUL 83 min read$BTMD

Is biote Corp. (BTMD) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Original reporting
Zacks Commentary · Zacks Equity Research
Published Jul 8, 2025, 1:40 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 9, 2025, 12:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Is biote Corp. (BTMD) Stock Undervalued Right Now? — source image
Source · www.zacks.com
Decision brief

The 30-second read

$BTMDBullishMed
01

Why it matters

The article suggests a potential buying opportunity based on valuation, but emphasizes the need for technical confirmation.

02

Market read

The news is moderately relevant for traders interested in biotech stocks, especially those seeking undervalued opportunities.

03

What to watch

Lack of current technical analysis, trading volume data, and broader market conditions could influence the stock's movement beyond valuation metrics.

Timing: short-term (next 1-3 months)

Background

Biote Corp. (BTMD) is a biotech company that has recently seen earnings estimate revisions, leading to speculation about its undervaluation.

Company-level read

Ticker impact

$BTMDBullishMedium confidence
Context

The article discusses Biote Corp. (BTMD) with a focus on its valuation status.

Expected impact

Potential upward movement in the stock price over the next 1-3 months, estimated at 10-15% increase if current trends persist.

Evidence & confidence

The analysis is based on recent earnings revisions and market sentiment, but lacks current technical indicators and volume data to confirm momentum.

Market effects

Sector

Potential positive sentiment for biotech and healthcare sectors if BTMD's valuation rally influences peer stocks.

Regional

Limited regional impact; primarily relevant to US markets.

Global

Low; the article's focus is on a US-based biotech company.

Counterpoint

What could challenge this read

The undervaluation may be due to underlying company risks or market skepticism, and the stock could remain stagnant or decline.

Key entities

  • Company
    Biote Corp.

    A biotech firm focused on developing innovative therapies.

Read at source← All news

Related articles

AUG 7
$BTMDMed

biote Q2 Earnings Call Highlights

Biote (NASDAQ: BTMD) reported Q2 net loss of $7.4M ($0.23/share) versus prior-year net income of $3.9M, and adjusted EBITDA of $5.6M (12.6% margin). Gross margin fell to 65.4% from 71.6% due to higher-cost third-party pellets during a disruption and $600k recall-related costs. Biote cut its 2026 outlook to revenue above $175M and adjusted EBITDA above $25M.

yahoo.com6 min
AUG 5
$BTMDMed

biote Corp. (BTMD): Results of Operations and Financial Condition

biote Corp. (BTMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 btmd-ex99_1.htm EX-99.1 EX-99.1 Biote Reports Second Quarter 2026 Financial Results Continued progress in advancing strategic initiatives Updates full-year outlook Second Quarter 2026 Financial Highlights • Revenue of $44.2 million • Gross profit margin of 65.4% • Net l

SEC EDGAR 8-K6 min
AUG 8
$RKLBMedAI 8/10

Rocket Lab Just Unveiled a Game-Changing Technology Worth Watching

Rocket Lab (RKLB) said it won a $397 million U.S. Space Force contract to develop, launch, and operate multiple Flatellites for the SB-AMTI program. Flatellites are slimmer, stackable satellites intended to increase deployments per launch and integrate with Rocket Lab’s Neutron rocket. The article cites analyst forecasts for revenue rising from $602M (2025) to $1.7B (2028).

fool.com6 min
AUG 8
$SUNEMedAI 8/10

Pentagon to invest $400m in Australian rare earth mine

Sunrise Energy Metals said the US Pentagon will provide a conditional $400 million loan commitment to develop Syerston, a proposed scandium mine in Fifield, NSW. The project targets Western supply of scandium used in defence and other sectors amid China’s export restrictions. Sunrise also said it has a deal with Lockheed Martin for 25% of output for five years.

bssnews.net4 min
AUG 8
$APLDMedAI 8/10

APLD Stock Rallies After Hours On Massive New $7.5 Billion Hyperscaler Lease: Retail Think Firm Should Be Worth More Than Rival IREN

Applied Digital (APLD) shares rose more than 7% after hours after the company said it surpassed 1 GW of contracted capacity for its AI data centers. It signed a 15-year take-or-pay lease for Polaris Forge 3 with a U.S. investment-grade hyperscaler, valued at about $7.5B base-term contracted revenue and up to $18.2B with renewals. Total contracted lease revenue across four campuses is $31B.

stocktwits.com4 min